Table 1 The clinicopathologic characteristics of nKlf4 and cKlf4 expression in NPC patients
Variables | Cases | nKlf4 (n, %) | cKlf4 (n, %) | ||||
|---|---|---|---|---|---|---|---|
Low | High | P | Low | High | P | ||
Gender | |||||||
 Male | 94 | 63 (67.0) | 31 (33.0) | 0.059 | 53 (56.4) | 41 (43.6) | 0.139 |
 Female | 74 | 39 (52.7) | 35 (47.3) |  | 50 (67.6) | 24 (32.4) |  |
Age (years) | |||||||
 < 54 | 87 | 53 (60.9) | 34 (39.1) | 0.955 | 55 (63.2) | 32 (36.8) | 0.599 |
 ≥ 54 | 81 | 49 (60.5) | 32 (39.5) |  | 48 (59.3) | 33 (40.7) |  |
T classification | |||||||
 T3 | 24 | 14 (58.3) | 10 (41.7) | 0.796 | 14 (58.3) | 10 (41.7) | 0.746 |
 T4 | 144 | 88 (61.1) | 56 (38.9) |  | 89 (61.8) | 55 (38.2) |  |
N classification | |||||||
 N0 | 87 | 56 (64.4) | 31 (35.6) | 0.315 | 51 (58.6) | 36 (41.4) | 0.458 |
 N1–3 | 81 | 46 (56.8) | 35 (43.2) |  | 52 (64.2) | 29 (35.8) |  |
M classification | |||||||
 M0 | 122 | 76 (62.3) | 46 (37.7) | 0.494 | 69 (56.6) | 53 (43.4) | 0.039 |
 M1 | 46 | 26 (56.5) | 20 (43.5) |  | 34 (73.9) | 12 (26.1) |  |
Clinical stage | |||||||
 III | 49 | 36 (73.5) | 13 (26.5) | 0.030 | 24 (49.0) | 25 (51.0) | 0.035 |
 IV | 119 | 66 (55.5) | 53 (44.5) |  | 79 (66.4) | 40 (33.6) |  |